A detailed history of Metis Global Partners, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Metis Global Partners, LLC holds 32,187 shares of ZTS stock, worth $5.33 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
32,187
Previous 30,676 4.93%
Holding current value
$5.33 Million
Previous $5.32 Million 18.26%
% of portfolio
0.2%
Previous 0.19%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$172.58 - $196.48 $260,768 - $296,881
1,511 Added 4.93%
32,187 $6.29 Million
Q2 2024

Aug 06, 2024

SELL
$145.54 - $178.83 $95,619 - $117,491
-657 Reduced 2.1%
30,676 $5.32 Million
Q1 2024

May 06, 2024

BUY
$165.67 - $199.94 $182,568 - $220,333
1,102 Added 3.65%
31,333 $5.3 Million
Q4 2023

Feb 06, 2024

SELL
$151.44 - $200.09 $43,766 - $57,826
-289 Reduced 0.95%
30,231 $5.97 Million
Q3 2023

Nov 07, 2023

BUY
$167.14 - $192.77 $501,587 - $578,502
3,001 Added 10.91%
30,520 $5.31 Million
Q2 2023

Aug 07, 2023

BUY
$160.94 - $186.23 $596,121 - $689,795
3,704 Added 15.55%
27,519 $4.74 Million
Q1 2023

May 08, 2023

BUY
$145.48 - $175.02 $531,002 - $638,823
3,650 Added 18.1%
23,815 $3.96 Million
Q4 2022

Feb 07, 2023

BUY
$131.14 - $157.47 $1.44 Million - $1.73 Million
10,965 Added 119.18%
20,165 $2.96 Million
Q3 2022

Nov 08, 2022

BUY
$148.29 - $182.55 $142,506 - $175,430
961 Added 11.66%
9,200 $1.36 Million
Q2 2022

Aug 08, 2022

BUY
$155.97 - $200.09 $119,473 - $153,268
766 Added 10.25%
8,239 $1.42 Million
Q1 2022

May 03, 2022

BUY
$181.39 - $234.03 $606,023 - $781,894
3,341 Added 80.86%
7,473 $1.41 Million
Q4 2021

Feb 11, 2022

BUY
$193.69 - $247.03 $800,327 - $1.02 Million
4,132 New
4,132 $1.01 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Metis Global Partners, LLC Portfolio

Follow Metis Global Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Metis Global Partners, LLC with notifications on news.